OKYO Pharma Limited

DB:OK10 Stock Report

Market Cap: €38.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

OKYO Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Gary Jacob

Chief executive officer

UK£1.2m

Total compensation

CEO salary percentage29.2%
CEO tenure2.6yrs
CEO ownershipn/a
Management average tenure2.6yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gary Jacob's remuneration changed compared to OKYO Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023UK£1mUK£351k

-UK£13m

Dec 31 2022n/an/a

-UK£11m

Sep 30 2022n/an/a

-UK£7m

Jun 30 2022n/an/a

-UK£5m

Mar 31 2022UK£2mUK£266k

-UK£5m

Dec 31 2021n/an/a

-UK£5m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£3m

Mar 31 2021UK£633kUK£62k

-UK£3m

Compensation vs Market: Gary's total compensation ($USD1.53M) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Gary's compensation has been consistent with company performance over the past year.

CEO

Gary Jacob (76 yo)

2.6yrs

Tenure

UK£1,202,916

Compensation

Dr. Gary S. Jacob, PhD, served as an Independent Director at Virpax Pharmaceuticals, Inc. since April 2020 until July 25, 2022. He had been an Independent Director of Cardiff Oncology, Inc. since February...

Leadership Team

NamePositionTenureCompensationOwnership
Gary Jacob
CEO & Executive Director2.6yrsUK£1.20mno data
Michael Beck
Founderno datano datano data
Keeren Shah
Chief Financial Officer3yrsno data0%
€ 0
Rajkumar Patil
Chief Scientific Officer2.4yrsno data0%
€ 0

2.6yrs

Average Tenure

65yo

Average Age

Experienced Management: OK10's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gary Jacob
CEO & Executive Director2.6yrsUK£1.20mno data
Bernard Denoyer
Independent Non-Executive Director1.7yrsUK£46.20kno data
Gabriele Marco Cerrone
Non-Executive Chairman2.6yrsUK£360.71kno data
John Brancaccio
Independent Non-Executive Director3.2yrsUK£51.07kno data
Jay Pepose
Member of Scientific Advisory Boardless than a yearno datano data
Willy Simon
Senior Independent Non-Executive Director7.8yrsUK£31.61kno data
Napoleone Ferrara
Member of Scientific Advisory Board3yrsno datano data
Pedram Hamrah
Member of Scientific Advisory Boardno datano datano data

2.6yrs

Average Tenure

72yo

Average Age

Experienced Board: OK10's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.